JFK Communications was the global PR agency for S-1 (Teysuno) for the first-line treatment of advanced gastric cancer. JFK Communications provided extensive global corporate and product public relations, including:
US and EU regulatory milestone support
Medical meeting support
KOL development and media training
Oncology Drugs Advisory Committee meeting support
Ready to tell your story?
JFK Communications Inc. 213 Carnegie Center Drive, Suite 7141 Princeton, NJ 08540